Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland.
about
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in TaiwanClinical risk factors for severe Clostridium difficile-associated disease.Multidrug resistance in European Clostridium difficile clinical isolates.tcdA As a diagnostic target in a loop-mediated amplification assay for detecting toxigenic Clostridium difficile.
P2860
Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@ast
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@en
type
label
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@ast
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@en
prefLabel
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@ast
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@en
P2093
P2860
P50
P356
P1476
Toxin profiles and resistances ...... difficile from Warsaw, Poland.
@en
P2093
Dorota Wultańska
Felicja Meisel-Mikołajczyk
Grazyna Nurzyńska
Hanna Pituch
Kees Maquelin
Martin Reijans
Mirosław Łuczak
Piotr Obuch-Woszczatyński
Willem van Leeuwen
P2860
P304
P356
10.1128/JCM.00306-07
P407
P50
P577
2007-02-21T00:00:00Z